Data Sheet 1_Global, regional, and national burden and risk factors of ischemic heart disease, 1990–2021: an analysis of the global burden of disease study.pdf حسب Quankai Cheng (21177656)

"…Background<p>With a rapidly growing and aging world population, ischemic heart disease (IHD) remains a major burden. …"

Data Sheet 1_Response surface-based media optimization for astaxanthin production in Corynebacterium glutamicum.docx حسب Florian Meyer (6913865)

"…Introduction<p>Astaxanthin is a C40 carotenoid that is used in animal feeds or cosmetics. …"

Table 1_Response surface-based media optimization for astaxanthin production in Corynebacterium glutamicum.xlsx حسب Florian Meyer (6913865)

"…Introduction<p>Astaxanthin is a C40 carotenoid that is used in animal feeds or cosmetics. …"

Renamed 05c60. حسب Hongjun Sun (12554742)

"…The Northern Coastal comprehensive economic zone has the highest contribution levels, followed by the Eastern and Southern Coastal zones, whereas the Northwestern and Northeastern zones have lower contribution levels. (2) The overall regional disparity in national standard development contribution levels is decreasing, with the largest intraregional disparities found in the Northern and Southern Coastal zones. …"

Region Division. حسب Hongjun Sun (12554742)

"…The Northern Coastal comprehensive economic zone has the highest contribution levels, followed by the Eastern and Southern Coastal zones, whereas the Northwestern and Northeastern zones have lower contribution levels. (2) The overall regional disparity in national standard development contribution levels is decreasing, with the largest intraregional disparities found in the Northern and Southern Coastal zones. …"

Data Sheet 1_Global burden and trends of childhood non-Hodgkin lymphoma from 1990 to 2021.pdf حسب Jing Xie (180526)

"…Background<p>Childhood non-Hodgkin lymphoma (NHL) is a significant contributor to pediatric cancer morbidity and mortality worldwide. …"

Table 2_Global burden and trends of childhood non-Hodgkin lymphoma from 1990 to 2021.docx حسب Jing Xie (180526)

"…Background<p>Childhood non-Hodgkin lymphoma (NHL) is a significant contributor to pediatric cancer morbidity and mortality worldwide. …"

Data Sheet 1_GBD: incidence rates and prevalence of anxiety disorders, depression and schizophrenia in countries with different SDI levels, 1990–2021.pdf حسب Jueqi Wang (21376073)

"…</p>Results<p>In countries with different SDI levels, the age-standardized average annual percentage change (AAPC) in the incidence of anxiety were all shown to be increasing, and there were large gender differences between the different SDI levels, with a maximum of 0.97 (0.76–1.18) for females in countries with a high SDI level, Age-standardized more rates per 100,000 people in high SDI countries, from 658.87 in 1990 to 841.56 in 2021, and the largest gender differences in countries with a low to moderate SDI level, with AAPCs for males and females of 0.04 (0.04–0.05), 0.86 (0.63–1.09); for depression, only the countries with medium-high SDI levels were statistically significant compared to the countries with medium-low SDI levels, with AAPCs of 0.05 (0.04–0.07), 0.04 (0.04–0.05); for schizophrenia in addition to the AAPCs of the countries with medium-high SDI levels showed an increase of 0.16 (0.13–0.18); the rest decreased.…"

Supplementary Material for: Minimal Change Disease and Focal Segmental Glomerulosclerosis are associated with good kidney prognosis and Thrombotic Microangiopathy with poor kidney... حسب Neves P.D.M.M. (20408168)

"…Herein we present the analysis of the first large Latin American cohort of adult patients undergoing kidney biopsy due to COVID-19-associated kidney disorders. …"

Supplementary Material for: The Bidirectional Casual Relationships between Chronic Inflammation and Intrinsic Capacity Decline: Insights from Mendelian Randomization Analysis حسب figshare admin karger (2628495)

"…Methods: We conducted a bidirectional MR analysis using summary-level data from large-scale genome-wide association studies (GWAS). …"

Data Sheet 1_Improving tea quality and fruit yield through intercropping with climbing plants.pdf حسب Qing Liao (1466149)

"…Tea polyphenol content decreased with increasing density, most notably in PE-H (−21.63% vs. …"

Image 2_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.jpeg حسب Ömer Bektaş (13827139)

"…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …"

Table 1_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx حسب Ömer Bektaş (13827139)

"…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …"

Image 1_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.jpeg حسب Ömer Bektaş (13827139)

"…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …"

Table 7_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx حسب Ömer Bektaş (13827139)

"…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …"

Table 6_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx حسب Ömer Bektaş (13827139)

"…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …"

Table 2_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx حسب Ömer Bektaş (13827139)

"…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …"

Table 4_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx حسب Ömer Bektaş (13827139)

"…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …"

Table 3_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx حسب Ömer Bektaş (13827139)

"…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …"

Table 5_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx حسب Ömer Bektaş (13827139)

"…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. CHOP-INTEND scores increased notably in all cohorts, with the largest improvement observed in Cohort A (93.5%). …"